Malignant pleural mesothelioma in Finland: regional and gender variation.

CONCLUSIONS: MPM is a disease with a poor prognosis, although chemotherapy appears to improve survival time. Significant gender and regional variation exists among patients, with notable differences in diagnostic and treatment practices. Long-term outcomes with pemetrexed remain indeterminate.
IMPACT: Emphasize centralized consult services for the diagnosis, treatment and support that patients receive for MPM, facilitating equal outcomes and compensation.
PMID: 30375909 [PubMed - as supplied by publisher]

Source: Acta Oncologica - October 30, 2018 Category: Cancer & Oncology Authors: Laaksonen S, Ilonen I, Kuosma E, Sutinen E, Wolff H, Vehmas T, Husgafvel-Pursiainen K, Salo JA, Koli K, Räsänen J, Myllärniemi M Tags: Acta Oncol Source Type: research